Position in GSK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$141,098,807
-$1,664,861 QoQ
Shares Held
2,691,698
+4.1% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#21
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 9%
None 8%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $19,386,650,383 across 15 Drug Manufacturers - General names. GSK ranks #12 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,003,417 | $4,801,818,850 | |
| 2 | JNJ |
Johnson & Johnson
|
15,385,556 | $3,907,469,656 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,486,486 | $2,247,013,450 | |
| 4 | ABBV |
AbbVie Inc.
|
7,236,861 | $1,821,083,699 | |
| 5 | NVS |
Novartis AG
|
8,117,586 | $1,272,188,077 | |
| 6 | AMGN |
Amgen Inc
|
3,413,981 | $1,236,270,798 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,691,951 | $1,134,650,214 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,899,794 | $998,059,971 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $141,098,807 | 2,691,698 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $142,763,668 | 2,586,767 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $122,573,222 | 2,499,454 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $107,663,999 | 2,494,532 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $99,163,199 | 2,582,375 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $99,979,687 | 2,580,787 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $87,883,636 | 2,598,570 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $105,473,587 | 2,580,078 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $86,868,319 | 2,256,320 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $72,309,084 | 1,686,706 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $65,881,375 | 1,777,695 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $63,767,736 | 1,759,110 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $60,619,538 | 1,700,885 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $54,264,977 | 1,525,154 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $54,097,746 | 1,539,492 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $54,822,349 | 1,862,805 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $99,592,900 | 2,332,702 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $99,586,986 | 2,330,957 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $100,978,501 | 2,334,586 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $87,360,449 | 2,331,081 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $93,108,792 | 2,384,015 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $86,127,827 | 2,460,461 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $88,917,669 | 2,463,541 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $102,487,995 | 2,776,150 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $127,184,199 | 3,179,062 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $118,248,771 | 3,181,937 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||